Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/S2665-9913(20)30386-6 http://scihub22266oqcxt.onion/10.1016/S2665-9913(20)30386-6 33521671!7834492!33521671     free     free     free       Lancet+Rheumatol 2021 ; 3 (1): e71-e82 Nephropedia Template TP {{tp|p=33521671|t=2021. Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective |pdf=|usr=}}{{33521671}} gab.com Text Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective JO: Lancet Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33521671 #FOAvip Giant cell arteritis, a common primary systemic vasculitis affecting older people, presents acutely as a medical emergency and requires rapid specialist assessment and treatment to prevent irreversible vision loss. Disruption of the health-care system caused by the COVID-19 pandemic exposed weak points in clinical pathways for diagnosis and treatment of giant cell arteritis, but has also permitted innovative solutions. The essential roles played by all professionals, including general practitioners and surgeons, in treating these patients have become evident. Patients must also be involved in the reshaping of clinical services. As an international group of authors involved in the care of patients with giant cell arteritis, we reflect in this Viewpoint on rapid service adaptations during the first peak of COVID-19, evaluate challenges, and consider implications for the future. Twit Text FOAVip Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective ????Lancet Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33521671 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33521671 #FOAvip English Wikipedia <ref>{{Cite pmid|33521671}}</ref> Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective #MMPMID33521671 Mackie SL; Brouwer E; Conway R; van der Geest KSM; Mehta P; Mollan SP; Neill L; Putman M; Robinson PC; Sattui SE Lancet Rheumatol 2021[Jan]; 3 (1): e71-e82 PMID33521671show ga Giant cell arteritis, a common primary systemic vasculitis affecting older people, presents acutely as a medical emergency and requires rapid specialist assessment and treatment to prevent irreversible vision loss. Disruption of the health-care system caused by the COVID-19 pandemic exposed weak points in clinical pathways for diagnosis and treatment of giant cell arteritis, but has also permitted innovative solutions. The essential roles played by all professionals, including general practitioners and surgeons, in treating these patients have become evident. Patients must also be involved in the reshaping of clinical services. As an international group of authors involved in the care of patients with giant cell arteritis, we reflect in this Viewpoint on rapid service adaptations during the first peak of COVID-19, evaluate challenges, and consider implications for the future. ?Clinical pathways for patients with giant cell arteritis during the CO(epmc).pdf DeepDyve Pubget Overpricing